Neuropharmacology and pain

Francisco Ciruela Alferez

PRINCIPAL INVESTIGATORS
  • Ester Aso Pérez
  • Jordi Bonaventura Morera
  • Víctor Fernández Dueñas
  • África Flores de los Heros
CLINICAL RESEARCHERS
  • Antoni Vallano Ferraz
  • Sebastián Videla Cés
  • Pilar Hereu Boher
  • Roser Llop Rius
  • Dolores Rodríguez Cumplido
COLLABORATORS
  • Maria Laura Cuffí Chéliz
  • Alex Fernandez Solanas
POSTDOCTORAL RESEARCHERS
  • Marc López Cano
PREDOCTORAL RESEARCHERS
  • Héctor Godoy Marín
  • Josep Argerich Bergadà
  • Laura Gómez Acero
  • Paula Álvarez Montoya
SCIENTIFIC SUPPORT
  • Maria Salut Sanchez Rodriguez
  • Aurema De Los Ángeles Otero Gonzalez
VISITING RESEARCHERS
  • Kristoffer Sahlholm
  • Jiu Lin
Neuroscience
Neuroscience

Scientific production

39

PAPERS

Impact factor: 231,996

10 PUBLICATIONS IN FIRST DECILE

27 PUBLICATIONS IN FIRST QUARTILE

30 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Valle-León, M., Callado, L. F., Aso, E., Cajiao-Manrique, M. M., Sahlholm, K., López-Cano, M., Soler, C., Altafaj, X., Watanabe, M., Ferré, S., Fernández-Dueñas, V., Menchón, J. M., & Ciruela, F. (2021). Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 46(3), 665–672. doi.org/10.1038/s41386-020-00872-9. IF:8,21
  • Morato X, Garcia Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borras E, Sabido E, Petaja Repo UE, Fernandez Duenas V, Ferrer I, Svenningsson P, Ciruela F. Ecto-GPR37: a potential biomarker for Parkinson’s disease. Transl Neurodegener. 2021;10(1):8-8. doi:10.1186/s40035-021-00232-7. IF:8,01. [Bernat: Ok,ha canviat ordre]
  • Videla S, Otero A, Marti S, Dominguez MA, Fabrellas N, Delgado Hito MP, Cruz I, Tebe C, Vinuesa T, Ardila F, Sancho M, Fernandez E, Figuerola M, Ciruela F. Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain. Int. J. Environ. Res. Public Health. 2021;18(12):doi:10.3390/ijerph18126526. IF:3,39.
  • López Cano M, Font J, Aso E, Sahlholm K, Cabré G, Giraldo J, De Koninck Y, Hernando J, Llebaria A, Fernández Dueñas V, Ciruela F. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. Br J Pharmacol. 1;doi:10.1111/bph.15645. IF: 7.95
  • Bejanin A, Iulita MF, Vilaplana E, Carmona Iragui M, Benejam B, Videla L, Barroeta I, Fernandez S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, Gonzalez Ortiz S, Munoz L, Padilla C, Aranha MR, Estelles T, Illan Gala I, Belbin O, Camacho V, Wilson LR, Annus T, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, Blennow K, Alcolea D, Clarimon J, Zaman SH, Blesa R, Lleo A, Fortea J. Association of Apolipoprotein E epsilon 4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. JAMA Neurol. 2021;78(8):937-947. doi:10.1001/jamaneurol.2021.1893. IF:18,30.

Research highlights

PROJECTS

15 Competitive projects

2 Clinical trials

PUBLISHED WORKS

3 Theses

NETWORKS

CannaLatan

Selected projects

  • 21INT002. Ecto-GPR37: a potential biomarker for Parkinson’s disease. (MJFF-001051). FUNDACIO IDIBELL; KAROLINSKA INSTITUTET; MICHAEL J FOX FOUNDATION. 2021-2023. IP: CIRUELA ALFEREZ, FRANCISCO.
  • 20FIS051. Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos. (PT17/0017/0001). FUNDACIO IDIBELL; FUNDACIÓN INVESTIGACIÓN BIOMÉDICA H; ISCIII. 2020-2021. IP:HEREU BOHER,PILAR.
  • 21DPS003. Subvencions per a la formació de científics i tecnòlegs: modalitat personal investigador en formació (PIF-Salut). (SLT017/20/000114). DIR.GEN.SALUT PUBLICA, DEP.SALUT GE. 2021-2024. IP: CIRUELA ALFEREZ, FRANCISCO.
  • 20CEE009. Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial. (733379). ECRIN – EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK. 2020-2022. IP:HEREU BOHER,PILAR.
  • 18FIS003. Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos. (PT17/0017/0010). ISCIII. 2018-2021. IP:HEREU BOHER,PILAR.